Constitutive STAT5 activation specifically cooperates with the loss of p53 function in B-cell lymphomagenesis

Oncogene

Volumn 25, Issue 33, 2006, Pages 4573-4584

  Joliot, V ^a,b   Cormier, F ^a   Medyouf, H ^a   Alcalde, H ^a   Ghysdael, J ^a  

^a INSTITUT CURIE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

B lymphocytes; Leukemia; Lymphoma; Oncogenic cooperation; p53; STAT5

Indexed keywords

CYTOKINE; DNA; MUTANT PROTEIN; PHENYLALANINE; PROTEIN P53; SERINE; STAT5 PROTEIN; STAT5A PROTEIN; STAT5B PROTEIN; TUMOR SUPPRESSOR PROTEIN; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; BINDING AFFINITY; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DNA BINDING; HEMATOPOIETIC CELL; LYMPHOMAGENESIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; ONCOLOGICAL PARAMETERS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL LINEAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, B-CELL; MICE; MICE, NUDE; MICE, TRANSGENIC; MODELS, GENETIC; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; POINT MUTATION; PROTEIN BINDING; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN P53;

MUS MUSCULUS;

EID: 33746859330     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209480     Document Type: Article

References (51)

1. Abraham N, Ma MC, Snow JW, Miners MJ, Herndier BG, Goldsmith MA. (2005). Oncogene 24: 5252-5257.
2. Aoki N, Matsuda T. (2000). J Biol Chem 275: 39718-39726.
3. Benekli M, Baer MR, Baumann H, Wetzler M. (2003). Blood 101: 2940-2954.
4. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM. (1994). EMBO J 13: 2124-2130.
5. Bowman T, Garcia R, Turkson J, Jove R. (2000). Oncogene 19: 2474-2488.
6. Bromberg J. (2002). J Clin Invest 109: 1139-1142.
7. Bunting KD, Bradley HL, Hawley TS, Moriggl R, Sorrentino BP, Ihle JN. (2002). Blood 99: 479-487.
8. Burchill MA, Goetz CA, Prlic M, O'Neil JJ, Harmon IR, Bensinger SJ et al. (2003). J Immunol 171: 5853-5864.
9. Carlesso N, Frank DA, Griffin JD. (1996). J Exp Med 183: 811-820.
10. Carron C, Cormier F, Janin A, Lacronique V, Giovannini M, Daniel MT et al. (2000). Blood 95: 3891-3899.
11. Chen Y, Wen R, Yang S, Schuman J, Zhang EE, Yi T et al. (2003). J Biol Chem 278: 16520-16527.
12. Cui Y, Riedlinger G, Miyoshi K, Tang W, Li C, Deng CX et al. (2004). Mol Cell Biol 24: 8037-8047.
13. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS et al. (1992). Nature 356: 215-221.
14. Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. (1999). Genes Dev 13: 2658-2669.
15. Fleming HE, Milne CD, Paige CJ. (2004). J Immunol 173: 2542-2551.
16. Fritsche M, Mundt M, Merkle C, Jahne R, Groner B. (1998). Mol Cell Endocrinol 143: 143-154.
17. Goetz CA, Harmon IR, O'Neil J J, Burchill MA, Johanns TM, Farrar MA. (2005). J Immunol 174: 7753-7763.
18. Goetz CA, Harmon IR, O'Neil JJ, Burchill MA, Farrar MA. (2004). J Immunol 172: 4770-4778.
19. Hemann MT, Fridman JS, Zilfou JT, Hernando E, Paddison PJ, Cordon-Cardo C et al. (2003). Nat Genet 33: 396-400.
20. Irie-Sasaki J, Sasaki T, Matsumoto W, Opavsky A, Cheng M, Welstead G et al. (2001). Nature 409: 349-354.
21. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA. (1994). Nat Genet 7: 353-361.
22. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al. (2005). Nature 434: 1144-1148.
23. Kang J, DiBenedetto B, Narayan K, Zhao H, Der SD, Chambers CA. (2004). J Immunol 173: 2307-2314.
24. Kelly J, Spolski R, Imada K, Bollenbacher J, Lee S, Leonard WJ. (2003a). J Immunol 170: 210-217.
25. Kelly JA, Spolski R, Kovanen PE, Suzuki T, Bollenbacher J, Pise-Masison CA et al. (2003b). J Exp Med 198: 79-89.
26. Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW. (2002). Gene 285: 1-24.
27. Krug U, Ganser A, Koeffler HP. (2002). Oncogene 21: 3475-3495.
28. Kuperwasser C, Hurlbut GD, Kittrell FS, Dickinson ES, Laucirica R, Medina D et al. (2000). Am J Pathol 157: 2151-2159.
29. Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M et al. (1997). Science 278: 1309-1312.
30. Lebigot I, Gardellin P, Lefebvre L, Beug H, Ghysdael J, Quang CT. (2003). Blood 102: 4555-4562.
31. Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ et al. (2005). Cancer Cell 7: 387-397.
32. Liu G, Parant JM, Lang G, Chau P, Chavez-Reyes A, El-Naggar AK et al. (2004). Nat Genet 36: 63-68.
33. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L. (1997). Genes Dev 11: 179-186.
34. Mizuki M, Fenski R, Halfter H, Matsumura I, Schmidt R, Muller C et al. (2000). Blood 96: 3907-3914.
35. Moriggl R, Sexl V, Kenner L, Duntsch C, Stangl K, Gingras S et al. (2005). Cancer Cell 7: 87-99.
36. Moriggl R, Sexl V, Piekorz R, Topham D, Ihle JN. (1999). Immunity 11: 225-230.
37. Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B et al. (1999). J Exp Med 189: 1229-1242.
38. Onishi M, Nosaka T, Misawa K, Mui AL, Gorman D, McMahon M et al. (1998). Mol Cell Biol 18: 3871-3879.
39. Reddy J, Shivapurkar N, Takahashi T, Parikh G, Stastny V, Echebiri C et al. (2005). Oncogene 24: 732-736.
40. Sambroock J, Fritisch E, Maniatis T. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New york.
41. Schmitt CA, Fridman JS, Yang M, Baranov E, Hoffman RM, Lowe SW. (2002). Cancer Cell 1: 289-298.
42. Schmitt CA, McCurrach ME, de Stanchina E, Wallace-Brodeur RR, Lowe SW. (1999). Genes Dev 13: 2670-2677.
43. Schwaller J, Parganas E, Wang D, Cain D, Aster JC, Williams IR et al. (2000). Mol Cell 6: 693-704.
44. Sexl V, Piekorz R, Moriggl R, Rohrer J, Brown MP, Bunting KD et al. (2000). Blood 96: 2277-2283.
45. Shuai K, Liu B. (2003). Nat Rev Immunol 3: 900-911.
46. Snow JW, Abraham N, Ma MC, Abbey NW, Herndier B, Goldsmith MA. (2002). Blood 99: 95-101.
47. Sommer VH, Clemmensen OJ, Nielsen O, Wasik M, Lovato P, Brender C et al. (2004). Leukemia 18: 1288-1295.
48. Sternberg DW, Gilliland DG. (2004). J Clin Oncol 22: 361-371.
49. Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D et al. (1998). Cell 93: 841-850.
50. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA et al. (1997). Proc Natl Acad Sci USA 94: 7239-7244.
51. Weber-Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux-Gruart V, Mertelsmann R et al. (1996). Blood 88: 809-816.